Replies to post #46661 on Bioelectronics Corp (BIEL)

[tjshooker]

I will play the devil's advocate here...
1)I think they have (or at least had)a pretty substantial amount of goods in the last report. IF they sold all that inventory, there would probably not be a need to dilute. IF they didn't sell them, then they would not need to produce more.
2)How much capital do you think they need to submit a 510k? That is all the final order would allow for. Once they have something generally approved (rx and/or Acti) with the FDA, I would imagine that financing and distribution (maybe an agreement?) is the easy part.